Director, HEOR Rare Blood Disorders
Sanofi, Cambridge, Massachusetts, USA
Cambridge, Massachusetts, United States
Alix Arnaud, MSc is a director of health economics and value assessment at Sanofi. She is a dedicated professional with a background in health economics and outcomes research (HEOR). Alix received her Master's degree in International Health Policy, specializing in Health Economics from the London School of Economics. Since, Alix has worked in HEOR in the pharmaceutical and biotechnology space conducting research to establish the burden of illness, unmet need and value of treatments for patients. Over the past decade, Alix has worked across disease areas including oncology, neuropsychology, and the autoimmune space. In 2022, Alix joined Sanofi with a focus on treatments for rare blood disorders area.
Alix's publication history includes systematic literature reviews and analyses of disease unment need, patient reported outcomes, indirect treatment comparisons and meta analyses, analyses of real world evidence spaning from adminsitrative claims and EMR analyses, registry and survey data, and observational studies as well as various types of economic and disease state models.